Nuvectis Pharma, Inc. Stock Forecast
High volatility in Nuvectis Pharma, Inc. stock price on Monday which ended trading at $7.56
(Updated on May 06, 2024)
The Nuvectis Pharma, Inc. stock price fell by -7.13% on the last day (Monday, 6th May 2024) from $8.14 to $7.56. During the last trading day the stock fluctuated 19.01% from a day low at $7.10 to a day high of $8.45. The price has fallen in 6 of the last 10 days but is still up by 6.48% over the past 2 weeks. Volume has increased on the last day by 79 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 185 thousand shares were bought and sold for approximately $1.40 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.63% during the next 3 months and, with a 90% probability hold a price between $5.03 and $8.39 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NVCT Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, April 30, 2024, and so far it has risen 24.34%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Nuvectis Pharma, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $7.58. On a fall, the stock will find some support from the short-term average at $6.87. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Nuvectis Pharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Nuvectis Pharma, Inc. stock
Nuvectis Pharma, Inc. finds support from accumulated volume at $7.46 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.35 between high and low, or 19.01%. For the last week, the stock has had daily average volatility of 14.53%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (NVCT) For The Upcoming Trading Day Of Tuesday 7th
For the upcoming trading day on Tuesday, 7th we expect Nuvectis Pharma, Inc. to open at $7.70, and during the day (based on 14 day Average True Range), to move between $6.80 and $8.32, which gives a possible trading interval of +/-$0.764 (+/-10.10%) up or down from last closing price. If Nuvectis Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 20.20% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $7.46 (1.32%) than the resistance at $8.77 (16.01%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Nuvectis Pharma, Inc. will release earnings BMO on Wednesday, May 08, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.400. We will update the financials statements for Nuvectis Pharma, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.04% in the first trading day after earnings release.
Is Nuvectis Pharma, Inc. stock A Buy?
Nuvectis Pharma, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Current score: -2.051 Sell Candidate Downgraded
Predicted Opening Price for Nuvectis Pharma, Inc. of Tuesday, May 7, 2024
Fair opening price May 7, 2024 | Current price |
---|---|
$7.70 ( 1.90%) | $7.56 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NVCT
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 9.05 | 19.75 % | |
R2 | 8.54 | 12.93 % | ||
R1 | 8.22 | 8.72 % | ||
Current price: | 7.56 | |||
Support | S1 | 7.19 | -4.93 % | |
S2 | 6.87 | -9.14 % | ||
S3 | 6.35 | -15.96 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 9.27 | 22.62 % | |
R2 | 9.15 | 21.03 % | ||
R1 | 8.77 | 16.01 % | ||
Current price | 7.56 | |||
Support | S1 | 7.46 | -1.32% | |
S2 | 6.41 | -15.21% | ||
S3 | 6.08 | -19.58% |
FAQ
Click here for our free guide on how to buy Nuvectis Pharma, Inc. Stock.